Advanced search
Publication Cover
Biomarkers Volume 25, 2020 - Issue 7
Submit an article Journal homepage
1,476
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

MR-proANP level predicts new onset atrial fibrillation in patients with acute myocardial infarction

Idzikowska KarolinaDepartment of Interventional Cardiology, Medical University of Lodz, Lodz, PolandCorrespondence[email protected]
,
Kacprzak MichałDepartment of Interventional Cardiology, Medical University of Lodz, Lodz, Poland
&
Zielińska MarzennaDepartment of Interventional Cardiology, Medical University of Lodz, Lodz, Poland
Pages 573-577 | Received 25 May 2020, Accepted 10 Aug 2020, Published online: 27 Sep 2020

References

  • Al-Khatib, S.M., et al., 2001. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. The american journal of cardiology, 88 (1), 76–79.
  • Anumonwo, J.M., and Kalifa, J., 2014. Risk factors and genetics of atrial fibrillation. Cardiology clinics, 32 (4), 485–494.
  • Crenshaw, B.S., et al., 1997. Atrail fibrillation in the setting of acute myocardial infarction: the GUSTO – I experience. Global Utilization of Streptokinase and TPA for occluded coronary arteries. Journal of the american college of cardiology, 30 (2), 406–413.
  • Dorje, T., et al., 2013. Plasma N-terminal pro-brain natriuretic peptide levels predict new-onset atrial fibrillation in patients with acute myocardial infarction. International journal of cardiology, 168 (3), 3135–3137.
  • Gedikli, O., et al., 2008. Association between serum C-reactive protein elevation and atrial fibrillation after first anterior myocardial infarction. Clinical cardiology, 31 (10), 482–487.
  • Guenancia CH, Stamboul, K., et al., 2014. Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factor. International journal of cardiology, 176 (3), 1039–1041.
  • He, J., et al., 2019. Clinical risk factors for new – onset atrial fibrillation in acute myocardial infarction. Medicine, 98 (26), e15960.
  • Idzikowska, K., and Zielińska, M., 2018. Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease. The journal of international medical research, 46 (8), 3017–3029.
  • Iqbal, Z., et al., 2019. New-onset atrial fibrillation in patients presenting with acute myocardial infarction. Cureus, 11 (4), e4483.
  • Lehto, M., et al., 2005. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAL experience. European heart journal, 26 (4), 350–356.
  • Mehta, R.H., et al., 2003. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am. J. Cardiol, 92 (9), 1031–1036.
  • Morgenthaler, N.G., et al., 2004. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clinical chemistry, 50 (1), 234–236.
  • Parashar, S., et al., 2013. New – onset atrial fibrillation after acute myocardial infarction and its relationship to admission biomarkers [from the TRIUMPH registry]. The American journal of cardiology, 112 (9), 1390–1395..
  • Parashar, S.L.J., et al., 2010. Elevated BNP predicts new onset atrial fibrillation complicating acute myocardial infarction: analysis of the TRIUMPH registry. Journal of the American college of cardiology, 55 (10), A7.E61.
  • Pizetti, F., et al., 2001. GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart, 86, 527–532.
  • Rathore, S.S., et al., 2000. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation, 101 (9), 969–974.
  • Rene, A.G., et al., 2014. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI trial). The American journal of cardiology, 113 (2), 236–242.
  • Rhyou, H.I., et al., 2018. Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI. Journal of cardiology, 71 (2), 125–128.
  • Sanchez, P.L., et al., 2003. Do baseline C-reactive protein levels predict the new-onset of atrial fibrillation in patients with acute coronary syndrome? European heart journal, 24 (5), 509.
  • Vukmirovic, M., et al., 2017. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction. Open medicine, 12, 115–124.
  • Yoshizaki, T., et al., 2012. Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Internal medicine, 51 (12), 1467–1471.
  • Zeng, R.X., et al., 2017. Left ventricular ejection fraction and left atrium diameter related to new-onset atrial fibrillation following acute myocardial infarction: systematic review and meta-analysis. Oncotarget, 8 (46), 81137–81144.
  • Zoni-Berisso, M., et al., 2014. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology, 6, 213–220.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.